Approval Year
Substance Class |
Polymer
Created
by
admin
on
Edited
Sat Dec 16 13:22:07 UTC 2023
by
admin
on
Sat Dec 16 13:22:07 UTC 2023
|
Record UNII |
ZZ45AB24CA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ESSENTIAL MEDICINES LIST |
10.2
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
||
|
WHO-ATC |
C05BA03
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
222106
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
694019
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
||
|
WHO-ATC |
B01AB01
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/05/337
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
||
|
NCI_THESAURUS |
C263
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1201657
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
ZZ45AB24CA
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
ZZ45AB24CA
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
C833
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
HEPARIN SODIUM
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | Description: A white or almost white powder. Solubility: Freely soluble in water. Category: Anticoagulant. Storage: Heparin sodium should be kept in a tightly closed container. Labelling: The designation Heparin sodium for parenteral use indicates that the substance complies with the additional requirements and may be used for parenteral administration. The label should also state the name and quantity of any added substances, and the source of the material (lung or mucosal). Expiry date. Additional information: Heparin sodium is moderately hygroscopic.Definition: Heparin sodium is a preparation containing the sodium salt of a sulfated glucosaminoglycan present in mammalian tissues. It has the characteristic property of delaying the clotting of fresh blood. Heparin sodium intended for the manufacture of a parenteral dosage form contains not less than 150 IU per mg, and Heparin sodium not intended for use in the manufacture of a parenteral dosage form contains not less than 120 IU per mg, both calculated with reference to the dried substance. | ||
|
314659
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
ALTERNATIVE | |||
|
9877
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
100000090150
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
DBSALT000417
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
SUB02478MIG
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY | |||
|
9041-08-1
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
GENERIC (FAMILY) | |||
|
392
Created by
admin on Sat Dec 16 13:22:07 UTC 2023 , Edited by admin on Sat Dec 16 13:22:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
DEGREE OF SULFATION | PHYSICAL |
|
SULFATE FRAGMENT
(not present in database)
|
|||
MOL_WEIGHT:WEIGHT AVERAGE | CHEMICAL |
|